New injection shows promise for painful eye disease
NCT ID NCT04311606
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study tested a drug called aflibercept, given as an injection near the eye, for people with active thyroid eye disease. The main goal was to see if the treatment is safe and tolerable. Eleven adults with mild to moderate disease activity received three injections over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mass Eye and Ear
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.